Some patients experience rapid initial drops of 3 to 5 pounds in the first week due to fluid loss and reduced caloric intake, while others see steadier, more gradual decline over several weeks
However, if your care team determines it is necessary to pause your medication to mitigate aspiration risks, the standard clinical protocol defaults back to how your specific GLP-1 is formulated: Daily Oral Formulations ( e.g., daily oral semaglutide or daily liraglutide ): Should generally be held on the day of the procedure
Liraglutide, dulaglutide, and semaglutide, three widely-used glucagon-like peptide-1 receptor agonists, have shown significant efficacy in diabetes treatment
However, semaglutide stands out as an available oral option, offering a convenient and weekly alternative for individuals who may have difficulty with injections